Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial

Mostrar otras versiones (1)

Background: The double-blind, 2 × 2 factorial design, placebo-controlled ASCEND randomized trial compared the effects of 100 mg aspirin daily and, separately, 1 g omega-3 fatty acids (FAs) daily on the primary prevention of cardiovascular disease in 15,480 UK adults with diabetes. We report the effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sammons, EL, Buck, G, Bowman, LJ, Stevens, WM, Hammami, I, Parish, S, Armitage, J
Formato:	Journal article
Lenguaje:	English
Publicado:	BioMed Central 2024

Ejemplares similares

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
por: Sammons, EL, et al.
Publicado: (2024)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
por: Emily L. Sammons, et al.
Publicado: (2024-11-01)

ASCEND-Eye: effects of aspirin on diabetic retinopathy
por: Sammons, E, et al.
Publicado: (2024)

ASCEND-Eye: effects of omega-3 fatty acids on diabetic retinopathy
por: Sammons, E, et al.
Publicado: (2023)

ASCEND-eye: rationale, design and baseline characteristics for a sub-study of the ASCEND randomized trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
por: Sammons, E, et al.
Publicado: (2023)

ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
por: Emily Sammons, et al.
Publicado: (2023-10-01)

Validity and reliability of the NEI VFQ-25 questionnaire in Indonesian leprosy patients
por: Tri Rahayu, et al.
Publicado: (2022-05-01)

Psychometric properties of the Greek version of the NEI-VFQ 25
por: Tsirouki Theodora, et al.
Publicado: (2008-03-01)

Near vision in patients with DME and RVO treated with aflibercept and correlation with NEI VFQ-25 questionnaire
por: Zuzana Anwarzai Sulavikova, et al.
Publicado: (2024-05-01)

Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version
por: Oki Kotaro, et al.
Publicado: (2005-10-01)

The ASCEND-Eye study: effect(s) of aspirin and omega-3 fatty acids on eye disease
por: Sammons, E
Publicado: (2023)

Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye
por: Smith Janine A, et al.
Publicado: (2004-09-01)

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
por: Parish, S, et al.
Publicado: (2022)

Is the NEI-VFQ-25 a useful tool in identifying visual impairment in an elderly population?
por: Wormald Richard PL, et al.
Publicado: (2006-06-01)

Validez de constructo de la escala NEI-VFQ-25 en una población colombiana
por: Diana Cristina Palencia Flórez, et al.

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
por: Bowman, L, et al.
Publicado: (2017)

The National Eye Institute 25-Item Visual Function Questionnaire (NEI VFQ-25) – reference data from the German population-based Gutenberg Health Study (GHS)
por: Stefan Nickels, et al.
Publicado: (2017-08-01)

Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
por: Aung, T, et al.
Publicado: (2017)

The Impact of Age-Related Macular Degeneration on Quality of Life and Its Association With Demographic Data: Results From the NEI VFQ-25 Questionnaire in a Norwegian Population
por: Ana Carla Schippert MScN, et al.
Publicado: (2018-09-01)

Confiabilidad de la escala NEI VFQ-25 en una población colombiana con enfermedad ocular crónica
por: Diana Cristina Palencia Flórez, et al.
Publicado: (2016-07-01)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
por: Parish, S, et al.
Publicado: (2023)

Chinese Version of the Vision-Related Quality of Life (NEI-VFQ-25) among Patients with Various Ocular Disorders: A Pilot Study
por: Jiahn-Shing Lee, et al.
Publicado: (2022-04-01)

Calidad de vida según la escala NEI VFQ-25 en la cirugía facorrefractiva de pacientes hipermétropes présbitas
por: Belkys Rodríguez Suárez, et al.

Correlation between contrast sensitivity and national eye institute visual function questionnaire (NEI VFQ-25) Rasch scores in patients with open-angle glaucoma: A cross-sectional study
por: Rieko Nakano, et al.
Publicado: (2025-02-01)

Vision-related quality of life among released from treatment cases of leprosy evaluated with NEI-VFQ-25: a cross-sectional study
por: Yunia Irawati, et al.
Publicado: (2023-10-01)

Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population
por: Elma Jelin, et al.
Publicado: (2019-08-01)

Comparison between the English and Bahasa Malaysia language versions of the Visual Functioning Questionnaire (VFQ-25) for use in patients with cataracts
por: Thanigasalam Thevi, et al.
Publicado: (2021-09-01)

Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes
por: Praveen Patel, et al.
Publicado: (2025-02-01)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
por: Sarah Parish, et al.
Publicado: (2023-03-01)

Development of age appropriate vision function questionnaire for children with visual impairment (CHVI-VFQ)
por: Meenakshi Wadhwani, et al.
Publicado: (2022-01-01)

Effects of omega−3 fatty acid supplements on arrhythmias
por: Parish, S, et al.
Publicado: (2020)

Thromboxane biosynthesis and future events in diabetes: the ASCEND trial
por: Petrucci, G, et al.
Publicado: (2024)

Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study
por: Mafham, MM, et al.
Publicado: (2019)

VfqI-VfqR quorum sensing circuit modulates type VI secretion system VflT6SS2 in Vibrio fluvialis
por: Yu Han, et al.
Publicado: (2022-09-01)

AFFINOID SUBDOMAINS AS COMPLETIONS OF AFFINE SUBDOMAINS
por: GHIOCEL GROZA
Publicado: (2016-07-01)

Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial
por: Rocca, B, et al.
Publicado: (2020)

Assessment of quality of life in patients with visual impairments using a new visual function questionnaire: the VFQ-J11
por: Nakano T, et al.
Publicado: (2016-10-01)

Effects of aspirin for primary prevention in persons with diabetes mellitus
por: Bowman, L, et al.
Publicado: (2018)

Psychometric validation techniques applied to the IND-VFQ-33 visual function questionnaire: the Hyderabad ocular morbidity in the elderly study (HOMES)
por: William Mitchell, et al.
Publicado: (2021-02-01)

Aspirin for primary prevention of vascular disease in people with diabetes.
por: Haynes, R, et al.
Publicado: (2009)